|
Specialty Pharmacy Clinical Policy Bulletins
Aetna Non-Medicare Prescription Drug Plan
Subject: Specialty Quantity Limit Cometriq 1858-H P2024_R
Policy: Program DescriptionThe standard limit is designed to allow a quantity sufficient for the most common uses of the medication. If member’s plan allows a quantity limit exception review for the requested medication, coverage of an additional quantity may be provided up to the exception limit with prior authorization. Covered QuantitiesCoverage up to the exception limits may be provided with prior authorization via the Specialty Post Limit Quantity Exception Criteria for approval.
FDA RECOMMENDED DOSING 140 mg orally once daily Dose may need to be modified based on adverse reactions, hepatic impairment, or drug interactions with strong CYP3A4 inducers or inhibitors. When used with a strong CYP3A4 inducer, increase the daily Cometriq dose by 40mg (for example, from 140 mg to 180 mg daily or from 100 mg to 140 mg daily) as tolerated. Place of Service: Outpatient The above policy is based on the following references:
January 01, 2025 |
|
Additional Information
|
|||||||||||||||
| Company Information | Site Map | Aetna.com Home | Help | Contact Us | Search |
|
Web Privacy Statement | Legal Statement | Privacy Notices | Member Disclosure
|